Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 

GlaxoSmithKline Buys Back 1.3 Million Shares

05/04/2012 | 12:28pm US/Eastern
Recommend:
0

GlaxoSmithKline PLC (>> GlaxoSmithKline plc) said Friday it has purchased 1,300,000 ordinary shares to be held in treasury.

MAIN FACTS:

-Highest price paid: 1455 pence per share.

-Lowest price paid: 1425 pence per share.

-Shares at 1610 GMT down 1%, at 1427 pence, valuing the company at GBP72 billion.

-By Mark Shapland, Dow Jones Newswires; +44 207 8429358; mark.shapland@dowjones.com

Stocks mentioned in the article : GlaxoSmithKline plc, GlaxoSmithKline plc
Recommend :
0
React to this article
Latest news on GLAXOSMITHKLINE PLC
1h ago GLAXOSMITHKLINE : GSK and Genmab receive FDA approval for Arzerra® (ofatumumab) ..
3h ago China's new breed of whistleblowers takes on big business
7h ago GLAXOSMITHKLINE : GSK announces approval in Canada for Incruse™ Ellipta&tr..
8h agoDJGLAXOSMITHKLINE : GSK Says Incruse Gets Approval in Canada for Treatment of Lung..
8h ago GLAXOSMITHKLINE : GSK announces approval in Canada for Incruse Ellipta (umeclidi..
8h ago GLAXOSMITHKLINE : GSK receives approval in Canada for Incruse
9h ago GLAXOSMITHKLINE : Glaxo COPD Treatment Incruse Ellipta Cleared In Canada
14h ago GSK, facing bribery claims, battles to build new sales model
14h ago GLAXOSMITHKLINE : Glaxo Confirms Investigations In Jordan, Lebanon Operations
19h ago GLAXOSMITHKLINE : Fresh bribery claims hit Glaxo
Advertisement
Chart
Duration : Period :
GlaxoSmithKline plc Technical Analysis Chart | GSK | GB0009252882 | 4-Traders
Income Statement Evolution
GlaxoSmithKline plc : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF